|4Feb 28, 4:25 PM ET

Alland Leila 4

4 · PMV Pharmaceuticals, Inc. · Filed Feb 28, 2022

Insider Transaction Report

Form 4
Period: 2022-02-10
Alland Leila
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2022-02-10+104,400104,400 total
    Exercise: $16.29Exp: 2032-02-10Common Stock (104,400 underlying)
Footnotes (1)
  • [F1]Shares subject to the option vest in 48 equal monthly installments beginning on March 10, 2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION